Beta Bionics, Inc. Common Stock

BBNXNASDAQ • USD
ThemeMedical Devices & HealthTech›Wearable Medical Devices
16.42 USD
↘ 0.09 (0.55%)AT CLOSE (03:59 PM EST)
16.41
↘ 0.01 (0.06%)
POST MARKET (AS OF 04:14 PM EST)
Post Market
AS OF 04:14 PM EST
16.41
↘ 0.01 (0.06%)
🔴Market: CLOSED

Beta Bionics, Inc. Common Stock (BBNX) trades at $16.42 per share. Technicals currently rate "Neutral" while our fundamental analysis reads "Neutral". This is driven by a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. On valuation, BBNX trades roughly in line with sector averages — neither particularly cheap nor expensive.

Technical & fundamental data as of Nov 13, 2026.

Open?$16.57
High?$17.53
Low?$16.09
Prev. Close?$16.51
Volume?1.1M
Avg. Volume?1.1M
VWAP?$16.46
Rel. Volume?0.99x
Bid / Ask
Bid?$13.10 × 1.0K
Ask?$18.00 × 600
Spread?$4.90
Midpoint?$15.55
Valuation & Ratios
Market Cap?892.7M
Shares Out?N/A
Float?28.4M
Float %?63.0%
P/E Ratio?N/A
P/B Ratio?2.22
EPS?-$1.53
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company's product includes the iLet Bionic Pancreas (iLet). The company operates as a single segment, focused on the development, manufacture, and sale of the iLet.
Themes
Medical Devices & HealthTech›Wearable Medical DevicesDigital Health & Telemedicine›Remote Patient Monitoring
Employees
423
Market Cap
897.6M
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
www.betabionics.com
Listed
2025-01-30
Address
11 HUGHES
IRVINE, CA 92618
Phone: 949-427-7785
Technical OutlookNeutral
Strong SellNeutralStrong Buy
Long-Term (Tide)?– Neutral(0/3)
Medium-Term (Wave)?▲ Bullish(+1/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
100
Momentum?
75
Short Sent.?
61
Piotroski F-Score?0/9Weak
Altman Z-Score?11.62Safe
Confidence?45%Low
Full Fundamental Analysis →
Short InterestHigh
Short % of Float?17.56%High
Short Interest?5.0M
Days to Cover?3.9
Free Float28.4M
Avg Daily Volume1.3M
Settlement Date2026-10-30
Financial Health
Current Ratio?8.92Strong
Quick Ratio?8.22Strong
Cash Ratio?2.48Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score
67/100
P/E?
N/A▾
P/B?
Peers
100
S&P
69
2.22CHEAP▾
P/S?
Peers
100
S&P
17
7.01HIGH▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-9.0CHEAP▾
EV/Sales?
Peers
100
S&P
25
6.37HIGH▾
Returns & Efficiency
ROE?
S&P
8
-20.7%WEAK▾
ROA?
S&P
3
-18.7%WEAK▾
Cash Flow & Enterprise
FCF?$-65962000
Enterprise Value?$811.2M
Fundamentals ratios updated end of day
MarketsMoversWatchlist